Article
In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung.
Brain research - 15 Aug 2021
Verma Amrita, Ebanks Kirsten, Fok Chi-Yee, Lewis Patrick A, Bettencourt Conceicao, Bandopadhyay Rina
Abstract excerpt
Mutations in LRRK2 are the most frequent cause of familial Parkinson's disease (PD), with common LRRK2 non-coding variants also acting as risk factors for idiopathic PD. Currently, therapeutic agents targeting LRRK2 are undergoing advanced clinical trials in humans, however, it is important to understand the wider implications of LRRK2 targeted treatments given that LRRK2 is expressed in diverse tissues including...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
